Back to Trades
Total Value
$1.8M
Filing Date
Mar 2, 2026
1 transaction
Grants
$1.6M
1 transaction
Trade Summary
On Feb 26, 2026 through Feb 28, 2026, Mutz Christopher, HEAD OF RARE DISEASE, received $1.8M of ANI PHARMACEUTICALS INC (ANIP) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $73.90 to $77.15. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- ANI PHARMACEUTICALS INC
- Ticker Symbol
- ANIP
- CIK
- 0001023024
Insider Information
- Name
- Mutz Christopher
- Role
- HEAD OF RARE DISEASE
- Location
- BAUDETTE, MN
Filing Details
- Filing Date
- Mar 2, 2026
- Transaction Date
- Feb 26, 2026
- Accession Number
- 0001846487-26-000008
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 26, 2026 | Common Stock | 21,306 | $77.15 | Grant/Award | $1.6M |
| Feb 28, 2026 | Common Stock | 2,221 | $73.90 | Tax Withholding | $164.1K |
Want live alerts when Mutz Christopher trades again?
Download Insider Trades to track ANIP, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026.
- (F2)Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported.